Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
New cell-based immunotherapy offered for melanoma (Links to an external site)
Tag: immunotherapy
David DeNardo, PhD Explores How the Tumor Microenvironment Affects Immune Responses to Cancer (Links to an external site)
David DeNardo, PhD, alongside his research team in the Tumor Immunology Program at Washington University School of Medicine, is working to understand why responses to cancer immunotherapy vary among patients.